clinical trials
Commercially sponsored trials now represent nearly 80% of all UK ATMP clinical trials,...
Increase of almost 30% in commercially sponsored clinical trials reveals a progression of ATMPs...
The UK and the NHS are providing the right environment and infrastructure to allow innovative...
Global industry shows confidence in cell and gene therapies and in UK’s ability to deliver these...
The Cell and Gene Therapy Catapult's database of UK clinical trial activity reveals an industry...
New research revealed by the Cell and Gene Therapy (CGT) Catapult today, indicates that the UK...
Cell and Gene Therapy Catapult are updating their clinical trials and preclinical programmes...
The UK pipeline of advanced therapy medicinal products (ATMPs) entering clinical development...
The number of advanced therapy medicinal product(1) (ATMP) clinical trials in the UK continues...